Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Alireza Rezayi

Alireza Rezayi

Shahid Beheshti University of Medical Sciences (SBMU, Iran

Hari Shanker Sharma

Hari Shanker Sharma

Uppsala University, Sweden

Suzanne D Gonzalez

Suzanne D Gonzalez

Texas Tech University Health Sciences Center, USA

Harish Pant

Harish Pant

National Institutes of Health, USA

Joel Schachter

Joel Schachter

Merck Research Laboratories, USA

David Truswell

David Truswell

somefreshthinking ltd, UK

Christina Francisca Vogelaar

Christina Francisca Vogelaar

University Medical Center, Germany

Michael V Ugrumov

Michael V Ugrumov

Institute of Developmental Biology RAS, Russia

Neuro Psychopharmacology 2018

About conference

Conference Series Ltd organizes a conference series of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

On behalf of Organizing Committee we invite all the participants from all part of the world to attend the “8th Global Experts Meeting on Nero Psychopharmacology 2018scheduled during March 21-22 at Bali, Indonesia

8th Global Experts Meeting on Neuro Psychopharmacology 2018 is the leading meeting dedicated to Neurologist, Psychiatrists, Researchers and Pharmacologist and Pharmaceuticals with the theme “Major Challenges and Breakthroughs in Neuropsychopharmacology”

It is a platform that provides an ideal combination of excellent science, an open atmosphere and allowing attendees and speakers to easily focus on academic exchange of ideas and authoritative views which covers the entire spectrum of research in neuropsychopharmacology.

8th Global Experts Meeting on Neuro Psychopharmacology 2018 is a unique forum to bring together worldwide distinguished academics in the field of Psychology and Psychiatry, Psychiatry researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies. The Conference will feature many exciting academic programs including multiple panels, workshops, affinity group lunches, paper presentations, and scientific sessions by reputed psychiatrists from all over the country. The goal of this conference is generate new ideas for treatment that will be beneficial across the spectrum of various neuropsychiatric disorders.

Target Audiences:

Directors

Vice Presidents

Neuropsychiatrist

Psychologist

Brand Manufacturers

Lecturers and Professors

Research scholars

Students from Academia in the study of Psychology, Neurology and Pharmacology

Why to attend?

We endeavor to make 8th Global Experts Meeting on Neuro Psychopharmacology 2018 a success, with your support and high quality talks from Neurological, Psychological as well as Pharmacological committees. We assure you that you will experience world class facilities and hospitality throughout the conference session.

With people from around the world focused on gathering some knowledge about neuropharmacology and its advances; this is your ultimate opportunity to accomplish the biggest collection of individuals from the Neuropsychopharmacology group. Broadly acclaimed speakers, the most recent techniques, researches, and the most state-of-the-art upgrades in Neuropharmacology are indications of this meeting.

Sessions/Tracks

Track 1: Neuropsychopharmacology

Neuropsychopharmacology is a multidisciplinary science that is a combination of both psychopharmacology (how drugs affect the mind) and neuroscience. It is the study of neural mechanism by which drugs act upon to influence behavior. It involves mechanisms of neuropathology, pharmacodynamics, psychiatric disorders, and states of consciousness. One of the ultimate aims is to design and develop prescriptions of treatment for a wide range of neuropathological conditions and psychiatric illness. The studies of psychotic disorders, anxiety disorders, degenerative disorders, affective disorders, eating behavior and sleep behavior may directly be influenced by the advancements in neuropsychopharmacology.

Related:  Neuropsychiatry 2018| Neuropsychiatry conferences| Neuropsychiatry conferences 2018| Psychology conferences | Neuropsychopharmacology | Psychopharmacology Meetings | Neuropsychiatry conferences Indonesia | Neuropharmacology conferences | Conference Series Ltd

5th International Conference on Brain Disorders and Therapeutics, November 29 – December  01, 2017 Madrid, Spain ; 9th International Conference on Alzheimer’s Disease & Dementia, October 16-18, 2017 Rome, Italy ; 16th International Conference on Neurology and Neuro Cognitive Disorders, October 09-10, 2017 London, UK; 7th Global Experts Meeting on Neuropharmacology July 31-Aug 02, 2017 Milan, Italy; 9th World Congress on Pharmacology, August 07-09, 2017 France;4th Clinical Trials Conference, September 11-13, 2017 San Antonio, USA; 8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 10th International Conference on Neuropharmacology and Neuropharmaceuticals, Oct 23-24, 2017 Dubai, UAE, American Board of Psychiatry and Neurology (ABPN), The American Clinical Neurophysiology Society (ACNS), ASEAN Neurological Association, Indonesian Psychological Society (HIMPSI), Indonesian pharmaceutical association (IPA), Asia Pacific Federation of Pharmacologists (ASCEPT), Indonesia Veterinary Pharmacy and Pharmacology Association (IVPPA)

 

Track 2: Neurotherapeutics

Neurotherapeutics are the drugs used for the treatment of psychological, psychiatric, and nervous disorders. In recent years there has been rapid progress in advancing new treatments for neurologic and psychiatric disorders. New therapeutics have emerged for the treatment of Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, epilepsy, schizophrenia, bipolar illness, depression, and drug abuse disorders. Progress in neurotherapeutics has occurred in concert with progress in basic science methodologies, neuroimaging, clinical trial design, and trial analysis. The objective of neurotherapeutics drug discovery and development is to identify new treatments that will improve the quality of life (QOL) of patients suffering from neurologic and psychiatric illness

Related:  Neuropsychiatry 2018| Neuropsychiatry conferences| Neuropsychiatry conferences 2018| Psychology conferences | Neuropsychopharmacology | Psychopharmacology Meetings | Neuropsychiatry conferences Indonesia | Neuropharmacology conferences | Conference Series Ltd

5th International Conference on Brain Disorders and Therapeutics, November 29 – December  01, 2017 Madrid, Spain ; 9th International Conference on Alzheimer’s Disease & Dementia, October 16-18, 2017 Rome, Italy ; 16th International Conference on Neurology and Neuro Cognitive Disorders, October 09-10, 2017 London, UK; 7th Global Experts Meeting on Neuropharmacology July 31-Aug 02, 2017 Milan, Italy; 9th World Congress on Pharmacology, August 07-09, 2017 France;4th Clinical Trials Conference, September 11-13, 2017 San Antonio, USA; 8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 10th International Conference on Neuropharmacology and Neuropharmaceuticals, Oct 23-24, 2017 Dubai, UAE, American Board of Psychiatry and Neurology (ABPN), The American Clinical Neurophysiology Society (ACNS), ASEAN Neurological Association, Indonesian Psychological Society (HIMPSI), Indonesian pharmaceutical association (IPA), Asia Pacific Federation of Pharmacologists (ASCEPT), Indonesia Veterinary Pharmacy and Pharmacology Association (IVPPA)

 

Track 3: Drug delivery system to CNS

Drug delivery is the method or process by which a target therapeutic agent is released in human to agents to achieve therapeutic effects. This results in increased efficacy and reduced adverse symptoms.  There are three broad categories: noninvasive, invasive, and miscellaneous techniques. Even though many substances have therapeutic effect on central nervous system (CNS) diseases, few of the agents have been clinically used because of the presence of a variety of formidable obstacles in the brain that impede drug delivery. This is attributes to the existence of blood brain barrier, which only permits some molecules to pass through the brain freely. In response to this, aggressive research efforts have focused on the development of new methodologies to deliver the drug molecules effectively to the brain.

Related:  Neuropsychiatry 2018| Neuropsychiatry conferences| Neuropsychiatry conferences 2018| Psychology conferences | Neuropsychopharmacology | Psychopharmacology Meetings | Neuropsychiatry conferences Indonesia | Neuropharmacology conferences | Conference Series Ltd

5th International Conference on Brain Disorders and Therapeutics, November 29 – December  01, 2017 Madrid, Spain ; 9th International Conference on Alzheimer’s Disease & Dementia, October 16-18, 2017 Rome, Italy ; 16th International Conference on Neurology and Neuro Cognitive Disorders, October 09-10, 2017 London, UK; 7th Global Experts Meeting on Neuropharmacology July 31-Aug 02, 2017 Milan, Italy; 9th World Congress on Pharmacology, August 07-09, 2017 France;4th Clinical Trials Conference, September 11-13, 2017 San Antonio, USA; 8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 10th International Conference on Neuropharmacology and Neuropharmaceuticals, Oct 23-24, 2017 Dubai, UAE, American Board of Psychiatry and Neurology (ABPN), The American Clinical Neurophysiology Society (ACNS), ASEAN Neurological Association, Indonesian Psychological Society (HIMPSI), Indonesian pharmaceutical association (IPA), Asia Pacific Federation of Pharmacologists (ASCEPT), Indonesia Veterinary Pharmacy and Pharmacology Association (IVPPA)

 

Track 4: Clinical trials in Psychopharmacology

Clinical trials of therapeutics are the experiments or observations that are carried out under standard conditions to learn whether the drugs or therapy work well enough, called "efficacy" or "effectiveness"; and to learn whether they are safe enough, called "safety”. While most clinical trials test one alternative to the novel intervention, some expand to three and may include a placebo. The most common clinical trials investigate the efficacy and safety of new pharmaceutical products, biologics, psychological therapies, or other interventions. Clinical trials are commonly classified into five phases namely I, II, III, IV and V. Each phase is treated as a separate clinical trial. The process of drug-development will normally pass through all the five phases over many years.

Related:  Neuropsychiatry 2018| Neuropsychiatry conferences| Neuropsychiatry conferences 2018| Psychology conferences | Neuropsychopharmacology | Psychopharmacology Meetings | Neuropsychiatry conferences Indonesia | Neuropharmacology conferences | Conference Series Ltd

5th International Conference on Brain Disorders and Therapeutics, November 29 – December  01, 2017 Madrid, Spain ; 9th International Conference on Alzheimer’s Disease & Dementia, October 16-18, 2017 Rome, Italy ; 16th International Conference on Neurology and Neuro Cognitive Disorders, October 09-10, 2017 London, UK; 7th Global Experts Meeting on Neuropharmacology July 31-Aug 02, 2017 Milan, Italy; 9th World Congress on Pharmacology, August 07-09, 2017 France;4th Clinical Trials Conference, September 11-13, 2017 San Antonio, USA; 8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 10th International Conference on Neuropharmacology and Neuropharmaceuticals, Oct 23-24, 2017 Dubai, UAE, American Board of Psychiatry and Neurology (ABPN), The American Clinical Neurophysiology Society (ACNS), ASEAN Neurological Association, Indonesian Psychological Society (HIMPSI), Indonesian pharmaceutical association (IPA), Asia Pacific Federation of Pharmacologists (ASCEPT), Indonesia Veterinary Pharmacy and Pharmacology Association (IVPPA)

 

Track 5: Behavioral pharmacology

Behavioral pharmacology is an interdisciplinary science field referred to as psychopharmacology. It deals with the study of action and effect of psycho-active, mood-altering drugs on behavior (drug-behavior interactions). Using techniques and approaches, it also analyzes how behavioral factors contribute to the use of psychotherapeutics such as anxiolytics, antidepressants, antipsychotics, and narcotics. It studies different drugs and substances ranging from widely-used, legal medications to obscure and illegal recreational drugs. Behavioral pharmacology involves examining all of the factors associated with behavioral illness, instead of just the biomedical aspect, and heals disease by including a component of behavioral change on the part of the patient.

Related:  Neuropsychiatry 2018| Neuropsychiatry conferences| Neuropsychiatry conferences 2018| Psychology conferences | Neuropsychopharmacology | Psychopharmacology Meetings | Neuropsychiatry conferences Indonesia | Neuropharmacology conferences | Conference Series Ltd

5th International Conference on Brain Disorders and Therapeutics, November 29 – December  01, 2017 Madrid, Spain ; 9th International Conference on Alzheimer’s Disease & Dementia, October 16-18, 2017 Rome, Italy ; 16th International Conference on Neurology and Neuro Cognitive Disorders, October 09-10, 2017 London, UK; 7th Global Experts Meeting on Neuropharmacology July 31-Aug 02, 2017 Milan, Italy; 9th World Congress on Pharmacology, August 07-09, 2017 France;4th Clinical Trials Conference, September 11-13, 2017 San Antonio, USA; 8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 10th International Conference on Neuropharmacology and Neuropharmaceuticals, Oct 23-24, 2017 Dubai, UAE, American Board of Psychiatry and Neurology (ABPN), The American Clinical Neurophysiology Society (ACNS), ASEAN Neurological Association, Indonesian Psychological Society (HIMPSI), Indonesian pharmaceutical association (IPA), Asia Pacific Federation of Pharmacologists (ASCEPT), Indonesia Veterinary Pharmacy and Pharmacology Association (IVPPA)

 

Track 6: Geriatric psychopharmacology

Geriatric psychiatry, also called as, psychogeriatrics is a branch of psychology that deals with prevention and treatment of mental illness in elderly people. Psychotropic therapeutic such as anti-depressants are commonly administered to older people to manage behavior and treat mental illness. These drugs are known to have potential adverse side effects on elderly as they are more sensitive to both the therapeutic and toxic effects of the drugs than young people. This necessitates lower doses and longer dosage intervals. It holds true for the treatment of 5 major types of psychiatric illness namely bipolar disorder depression, anxiety, psychotic disorders and dementia. The diagnosis, treatment and management of dementia and depression are two areas of this field. Psychopharmacotherapy must take into account the effects of age-related changes in the structure and function of the brain and various organs.

Related:  Neuropsychiatry 2018| Neuropsychiatry conferences| Neuropsychiatry conferences 2018| Psychology conferences | Neuropsychopharmacology | Psychopharmacology Meetings | Neuropsychiatry conferences Indonesia | Neuropharmacology conferences | Conference Series Ltd

5th International Conference on Brain Disorders and Therapeutics, November 29 – December  01, 2017 Madrid, Spain ; 9th International Conference on Alzheimer’s Disease & Dementia, October 16-18, 2017 Rome, Italy ; 16th International Conference on Neurology and Neuro Cognitive Disorders, October 09-10, 2017 London, UK; 7th Global Experts Meeting on Neuropharmacology July 31-Aug 02, 2017 Milan, Italy; 9th World Congress on Pharmacology, August 07-09, 2017 France;4th Clinical Trials Conference, September 11-13, 2017 San Antonio, USA; 8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 10th International Conference on Neuropharmacology and Neuropharmaceuticals, Oct 23-24, 2017 Dubai, UAE, American Board of Psychiatry and Neurology (ABPN), The American Clinical Neurophysiology Society (ACNS), ASEAN Neurological Association, Indonesian Psychological Society (HIMPSI), Indonesian pharmaceutical association (IPA), Asia Pacific Federation of Pharmacologists (ASCEPT), Indonesia Veterinary Pharmacy and Pharmacology Association (IVPPA)

 

Track 7: Molecular neuropharmacology

Molecular neuropharmacology is the branch of pharmacology that deals with the study of neuropharmaceutical in molecular level. The discipline of pharmacology studies the effect of drugs on living beings. Molecular pharmacology uses methods in molecular biology to do this. Molecular biology started to have an impact on neuropharmacology to start the era of molecular pharmacology. Molecular targets of drugs acting on CNS were identified and increasing molecular understanding of the receptors has enabled improved drug design. Molecular imaging plays an important role in neuropharmacology and provides key biomarkers as a bridge from the laboratory to clinical in CNS drug development. Understanding the molecular structure of drugs used for treatment of neurological disorders is also important.

Related:  Neuropsychiatry 2018| Neuropsychiatry conferences| Neuropsychiatry conferences 2018| Psychology conferences | Neuropsychopharmacology | Psychopharmacology Meetings | Neuropsychiatry conferences Indonesia | Neuropharmacology conferences | Conference Series Ltd

5th International Conference on Brain Disorders and Therapeutics, November 29 – December  01, 2017 Madrid, Spain ; 9th International Conference on Alzheimer’s Disease & Dementia, October 16-18, 2017 Rome, Italy ; 16th International Conference on Neurology and Neuro Cognitive Disorders, October 09-10, 2017 London, UK; 7th Global Experts Meeting on Neuropharmacology July 31-Aug 02, 2017 Milan, Italy; 9th World Congress on Pharmacology, August 07-09, 2017 France;4th Clinical Trials Conference, September 11-13, 2017 San Antonio, USA; 8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 10th International Conference on Neuropharmacology and Neuropharmaceuticals, Oct 23-24, 2017 Dubai, UAE, American Board of Psychiatry and Neurology (ABPN), The American Clinical Neurophysiology Society (ACNS), ASEAN Neurological Association, Indonesian Psychological Society (HIMPSI), Indonesian pharmaceutical association (IPA), Asia Pacific Federation of Pharmacologists (ASCEPT), Indonesia Veterinary Pharmacy and Pharmacology Association (IVPPA)

 

Track 8: Drugs for cognitive enhancement

Cognitive enhancers are therapeutics/drugs that can be used to increase the brain’s function on cognitive measurements such as memory, reasoning, attention, learning and mood.  In the scientific community, these cognitive enhancers are also known as smart drugs or as nootropics. The intellectual functions are enhanced by these drugs by affording a high level of neurotransmitters to the brain and triggering important receptors. Use of these cognition-enhancers by healthy individuals in the absence of a medical indication is one of the most controversial topics among, psychiatrists, neuroscientists and physicians. Only a few drugs are known to enhance the aspect of cognition.  Stimulants, such as caffeine is the most commonly used class of drug.

Related:  Neuropsychiatry 2018| Neuropsychiatry conferences| Neuropsychiatry conferences 2018| Psychology conferences | Neuropsychopharmacology | Psychopharmacology Meetings | Neuropsychiatry conferences Indonesia | Neuropharmacology conferences | Conference Series Ltd

5th International Conference on Brain Disorders and Therapeutics, November 29 – December  01, 2017 Madrid, Spain ; 9th International Conference on Alzheimer’s Disease & Dementia, October 16-18, 2017 Rome, Italy ; 16th International Conference on Neurology and Neuro Cognitive Disorders, October 09-10, 2017 London, UK; 7th Global Experts Meeting on Neuropharmacology July 31-Aug 02, 2017 Milan, Italy; 9th World Congress on Pharmacology, August 07-09, 2017 France;4th Clinical Trials Conference, September 11-13, 2017 San Antonio, USA; 8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 10th International Conference on Neuropharmacology and Neuropharmaceuticals, Oct 23-24, 2017 Dubai, UAE, American Board of Psychiatry and Neurology (ABPN), The American Clinical Neurophysiology Society (ACNS), ASEAN Neurological Association, Indonesian Psychological Society (HIMPSI), Indonesian pharmaceutical association (IPA), Asia Pacific Federation of Pharmacologists (ASCEPT), Indonesia Veterinary Pharmacy and Pharmacology Association (IVPPA)

 

Track 9: Pharmacotherapy

Pharmacotherapy, as the name suggests, is the process that involves the use of psychotropic drugs for the treatment mental health symptoms and disorders. The study of effects of these drugs is called as pharmacotherapeutics. It comprises knowledge of the sources, chemical properties, biological effects and therapeutic uses of drugs. It is combined with other treatment methods, like physical therapy and diet therapy. Modern pharmacotherapy includes the use of psychotropic, hormonal preparations, chemotherapeutic, and other effective drugs. Some of the pharmaco therapeutics used for treating mental illness includes:

Related:  Neuropsychiatry 2018| Neuropsychiatry conferences| Neuropsychiatry conferences 2018| Psychology conferences | Neuropsychopharmacology | Psychopharmacology Meetings | Neuropsychiatry conferences Indonesia | Neuropharmacology conferences | Conference Series Ltd

5th International Conference on Brain Disorders and Therapeutics, November 29 – December  01, 2017 Madrid, Spain ; 9th International Conference on Alzheimer’s Disease & Dementia, October 16-18, 2017 Rome, Italy ; 16th International Conference on Neurology and Neuro Cognitive Disorders, October 09-10, 2017 London, UK; 7th Global Experts Meeting on Neuropharmacology July 31-Aug 02, 2017 Milan, Italy; 9th World Congress on Pharmacology, August 07-09, 2017 France;4th Clinical Trials Conference, September 11-13, 2017 San Antonio, USA; 8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 10th International Conference on Neuropharmacology and Neuropharmaceuticals, Oct 23-24, 2017 Dubai, UAE, American Board of Psychiatry and Neurology (ABPN), The American Clinical Neurophysiology Society (ACNS), ASEAN Neurological Association, Indonesian Psychological Society (HIMPSI), Indonesian pharmaceutical association (IPA), Asia Pacific Federation of Pharmacologists (ASCEPT), Indonesia Veterinary Pharmacy and Pharmacology Association (IVPPA)

 

Track 10: Novel therapeutic approaches in Repeat expansion Disorders

In the recent years, the underlying mutations for some acquired neurodegenerative diseases have been identified. One continuous sort of change is trinucleotide repeat expansion. It is otherwise called trinucleotide repeat expansion disorder or trinucleotide repeats disorder and is a set of genetic disorder caused by an expansion in the quantity of trinucleotide repeats in specific genes. Each gene influenced by trinucleotide repeat expansion has a different number of repeats those results in sign of sickness. Further understanding of the role of inflammation in the pathogenesis of TREDs may allow for the design of better therapeutic approaches, slowing disease progression and improving the life of patients.

Related:  Neuropsychiatry 2018| Neuropsychiatry conferences| Neuropsychiatry conferences 2018| Psychology conferences | Neuropsychopharmacology | Psychopharmacology Meetings | Neuropsychiatry conferences Indonesia | Neuropharmacology conferences | Conference Series Ltd

5th International Conference on Brain Disorders and Therapeutics, November 29 – December  01, 2017 Madrid, Spain ; 9th International Conference on Alzheimer’s Disease & Dementia, October 16-18, 2017 Rome, Italy ; 16th International Conference on Neurology and Neuro Cognitive Disorders, October 09-10, 2017 London, UK; 7th Global Experts Meeting on Neuropharmacology July 31-Aug 02, 2017 Milan, Italy; 9th World Congress on Pharmacology, August 07-09, 2017 France;4th Clinical Trials Conference, September 11-13, 2017 San Antonio, USA; 8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 10th International Conference on Neuropharmacology and Neuropharmaceuticals, Oct 23-24, 2017 Dubai, UAE, American Board of Psychiatry and Neurology (ABPN), The American Clinical Neurophysiology Society (ACNS), ASEAN Neurological Association, Indonesian Psychological Society (HIMPSI), Indonesian pharmaceutical association (IPA), Asia Pacific Federation of Pharmacologists (ASCEPT), Indonesia Veterinary Pharmacy and Pharmacology Association (IVPPA)

 

Track 11: Psychological interventions

Psychological interventions are actions that are carried out to bring about behavioral changes in people. There are various applications of psychological interventions and the most commonly used in the treatment of mental disorders using psychotherapy. In addition to the attenuation of the symptoms of neural disorder, the intervention is also aimed at identifying the root cause of the disorder. It helps to changing behaviors that prevents violent behavior, promote healthy patterns of diet and exercise, improve children's learning and performance in school, control alcohol abuse, manages the aggressive behavior in children, reduces major depression.

Related:  Neuropsychiatry 2018| Neuropsychiatry conferences| Neuropsychiatry conferences 2018| Psychology conferences | Neuropsychopharmacology | Psychopharmacology Meetings | Neuropsychiatry conferences Indonesia | Neuropharmacology conferences | Conference Series Ltd

5th International Conference on Brain Disorders and Therapeutics, November 29 – December  01, 2017 Madrid, Spain ; 9th International Conference on Alzheimer’s Disease & Dementia, October 16-18, 2017 Rome, Italy ; 16th International Conference on Neurology and Neuro Cognitive Disorders, October 09-10, 2017 London, UK; 7th Global Experts Meeting on Neuropharmacology July 31-Aug 02, 2017 Milan, Italy; 9th World Congress on Pharmacology, August 07-09, 2017 France;4th Clinical Trials Conference, September 11-13, 2017 San Antonio, USA; 8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 10th International Conference on Neuropharmacology and Neuropharmaceuticals, Oct 23-24, 2017 Dubai, UAE, American Board of Psychiatry and Neurology (ABPN), The American Clinical Neurophysiology Society (ACNS), ASEAN Neurological Association, Indonesian Psychological Society (HIMPSI), Indonesian pharmaceutical association (IPA), Asia Pacific Federation of Pharmacologists (ASCEPT), Indonesia Veterinary Pharmacy and Pharmacology Association (IVPPA)

 

Track 12: Advancement in Cognitive Neuroscience

Cognitive science is the interdisciplinary examination of mind and intelligence, psychology, neuroscience, linguistics, philosophy and computational intelligence. This area has a more narrow focus than that of psychotechnology. The first advancement is that cognitive neuroscience is becoming more and more central to all branches of psychology. Advancement in cognitive neuroscience also has important implications for conventional philosophical topics such as the mind-body problem, free will, and even the meaning of life. Cognitive science will continue to progress and that advances in areas such as theoretical neuroscience will provide solution to some of the most challenging questions about the mind. In the past, our knowledge of what is happening in the brain was restricted. Few individuals were examined after death. Now there is a wide range of technologies routinely used in many applications. These technologies are also used to study cognitive development in childhood to understand how the brain develops early on.

Related:  Neuropsychiatry 2018| Neuropsychiatry conferences| Neuropsychiatry conferences 2018| Psychology conferences | Neuropsychopharmacology | Psychopharmacology Meetings | Neuropsychiatry conferences Indonesia | Neuropharmacology conferences | Conference Series Ltd

5th International Conference on Brain Disorders and Therapeutics, November 29 – December  01, 2017 Madrid, Spain ; 9th International Conference on Alzheimer’s Disease & Dementia, October 16-18, 2017 Rome, Italy ; 16th International Conference on Neurology and Neuro Cognitive Disorders, October 09-10, 2017 London, UK; 7th Global Experts Meeting on Neuropharmacology July 31-Aug 02, 2017 Milan, Italy; 9th World Congress on Pharmacology, August 07-09, 2017 France;4th Clinical Trials Conference, September 11-13, 2017 San Antonio, USA; 8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 10th International Conference on Neuropharmacology and Neuropharmaceuticals, Oct 23-24, 2017 Dubai, UAE, American Board of Psychiatry and Neurology (ABPN), The American Clinical Neurophysiology Society (ACNS), ASEAN Neurological Association, Indonesian Psychological Society (HIMPSI), Indonesian pharmaceutical association (IPA), Asia Pacific Federation of Pharmacologists (ASCEPT), Indonesia Veterinary Pharmacy and Pharmacology Association (IVPPA)

 

Track 13: Novel approaches in Neuropharmacology

Neuropharmacology is a progressive field of pharmacology that is exponentially growing with the understanding of nervous system and its related disorders, therapeutics and treatments. The various area of research included in this field are mechanisms of novel therapeutics, neuro stem cell therapy, gene therapy in neuronal disorders and neural engineering. Major approaches in scientific discovery and understandings can result from the development and use of new methodologies. The significance of these new methods and therapeutic approaches has the potential to have a major impact on basic and clinical research in pharmacology and toxicology as well as on patient care.

Related:  Neuropsychiatry 2018| Neuropsychiatry conferences| Neuropsychiatry conferences 2018| Psychology conferences | Neuropsychopharmacology | Psychopharmacology Meetings | Neuropsychiatry conferences Indonesia | Neuropharmacology conferences | Conference Series Ltd

5th International Conference on Brain Disorders and Therapeutics, November 29 – December  01, 2017 Madrid, Spain ; 9th International Conference on Alzheimer’s Disease & Dementia, October 16-18, 2017 Rome, Italy ; 16th International Conference on Neurology and Neuro Cognitive Disorders, October 09-10, 2017 London, UK; 7th Global Experts Meeting on Neuropharmacology July 31-Aug 02, 2017 Milan, Italy; 9th World Congress on Pharmacology, August 07-09, 2017 France;4th Clinical Trials Conference, September 11-13, 2017 San Antonio, USA; 8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 10th International Conference on Neuropharmacology and Neuropharmaceuticals, Oct 23-24, 2017 Dubai, UAE, American Board of Psychiatry and Neurology (ABPN), The American Clinical Neurophysiology Society (ACNS), ASEAN Neurological Association, Indonesian Psychological Society (HIMPSI), Indonesian pharmaceutical association (IPA), Asia Pacific Federation of Pharmacologists (ASCEPT), Indonesia Veterinary Pharmacy and Pharmacology Association (IVPPA)

 

Track 14: Neurotoxicology

It is branch that is concerned with the study of effect of poison on nervous system. Neurotoxins are substances that affect the normal activity of the nervous system and cause damage to nervous tissue. Neurotoxicity can result from exposure to substances used drug therapies, chemotherapy, radiation treatment, and certain drug abuse. Common symptoms can include loss of memory, concentration, mental processing speed, sleep, compulsive behaviors anxiety, depression, fatigue, numbness of the hands and feet and cognitive and behavioral problems and sexual dysfunction. Individuals with certain disorders may be especially vulnerable to neurotoxins.

Related:  Neuropsychiatry 2018| Neuropsychiatry conferences| Neuropsychiatry conferences 2018| Psychology conferences | Neuropsychopharmacology | Psychopharmacology Meetings | Neuropsychiatry conferences Indonesia | Neuropharmacology conferences | Conference Series Ltd

5th International Conference on Brain Disorders and Therapeutics, November 29 – December  01, 2017 Madrid, Spain ; 9th International Conference on Alzheimer’s Disease & Dementia, October 16-18, 2017 Rome, Italy ; 16th International Conference on Neurology and Neuro Cognitive Disorders, October 09-10, 2017 London, UK; 7th Global Experts Meeting on Neuropharmacology July 31-Aug 02, 2017 Milan, Italy; 9th World Congress on Pharmacology, August 07-09, 2017 France;4th Clinical Trials Conference, September 11-13, 2017 San Antonio, USA; 8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 10th International Conference on Neuropharmacology and Neuropharmaceuticals, Oct 23-24, 2017 Dubai, UAE, American Board of Psychiatry and Neurology (ABPN), The American Clinical Neurophysiology Society (ACNS), ASEAN Neurological Association, Indonesian Psychological Society (HIMPSI), Indonesian pharmaceutical association (IPA), Asia Pacific Federation of Pharmacologists (ASCEPT), Indonesia Veterinary Pharmacy and Pharmacology Association (IVPPA)

 

Track 15: Neurocognitive disorders

Neurocognitive disorders are a group of conditions that usually lead to an impaired mental function. The conditions associated with these disorders are brain injury caused by trauma, cardiovascular disorders, degenerative disorders, drug and alcohol-related conditions etc. The major degenerative causes of neurocognitive disorder are Alzheimer’s and vascular dementia. Neurodegenerative diseases cause the brain and nerves to deteriorate over time, resulting in a gradual loss of neurological function. Neurocognitive disorders can affect memory, attention, learning, language, perception, and social cognition. The risk of developing neurocognitive disorders partly depends on individual’s lifestyle and daily habits.

Related:  Neuropsychiatry 2018| Neuropsychiatry conferences| Neuropsychiatry conferences 2018| Psychology conferences | Neuropsychopharmacology | Psychopharmacology Meetings | Neuropsychiatry conferences Indonesia | Neuropharmacology conferences | Conference Series Ltd

5th International Conference on Brain Disorders and Therapeutics, November 29 – December  01, 2017 Madrid, Spain ; 9th International Conference on Alzheimer’s Disease & Dementia, October 16-18, 2017 Rome, Italy ; 16th International Conference on Neurology and Neuro Cognitive Disorders, October 09-10, 2017 London, UK; 7th Global Experts Meeting on Neuropharmacology July 31-Aug 02, 2017 Milan, Italy; 9th World Congress on Pharmacology, August 07-09, 2017 France;4th Clinical Trials Conference, September 11-13, 2017 San Antonio, USA; 8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 10th International Conference on Neuropharmacology and Neuropharmaceuticals, Oct 23-24, 2017 Dubai, UAE, American Board of Psychiatry and Neurology (ABPN), The American Clinical Neurophysiology Society (ACNS), ASEAN Neurological Association, Indonesian Psychological Society (HIMPSI), Indonesian pharmaceutical association (IPA), Asia Pacific Federation of Pharmacologists (ASCEPT), Indonesia Veterinary Pharmacy and Pharmacology Association (IVPPA)

 

Track 16: Alzheimer’s disease

Alzheimer’s disease is a neurological disorder that is progressive and irreversible, destroying the memory and other important mental functions. It is a chronic disease that usually starts slowly and gets worse over time resulting in inability to carry out simple tasks. The main features of this Alzheimer’s disease are the plaques and tangles formed in the brain. Another feature is the loss of connections between neurons in the brain. The most common early symptom is short-term memory loss and as it advances, symptoms can include problems with language, mood swings, and behavioral issues. The progress in the disease results in loss of the bodily functions and ultimately leads to death.

Related:  Neuropsychiatry 2018| Neuropsychiatry conferences| Neuropsychiatry conferences 2018| Psychology conferences | Neuropsychopharmacology | Psychopharmacology Meetings | Neuropsychiatry conferences Indonesia | Neuropharmacology conferences | Conference Series Ltd

5th International Conference on Brain Disorders and Therapeutics, November 29 – December  01, 2017 Madrid, Spain ; 9th International Conference on Alzheimer’s Disease & Dementia, October 16-18, 2017 Rome, Italy ; 16th International Conference on Neurology and Neuro Cognitive Disorders, October 09-10, 2017 London, UK; 7th Global Experts Meeting on Neuropharmacology July 31-Aug 02, 2017 Milan, Italy; 9th World Congress on Pharmacology, August 07-09, 2017 France;4th Clinical Trials Conference, September 11-13, 2017 San Antonio, USA; 8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 10th International Conference on Neuropharmacology and Neuropharmaceuticals, Oct 23-24, 2017 Dubai, UAE, American Board of Psychiatry and Neurology (ABPN), The American Clinical Neurophysiology Society (ACNS), ASEAN Neurological Association, Indonesian Psychological Society (HIMPSI), Indonesian pharmaceutical association (IPA), Asia Pacific Federation of Pharmacologists (ASCEPT), Indonesia Veterinary Pharmacy and Pharmacology Association (IVPPA)

 

Track 17: Dementia

Dementia is a syndrome that results in loss of memory and other mental abilities severe enough to interfere with daily life. Many diseases can cause dementia, including Alzheimer's disease, vascular dementia, Parkinson’s disease, and Huntington’s disease. It is caused by physical changes that are caused in the brain. Dementia is usually observed in people over the age of 65. Symptoms may include memory loss and difficulties with thinking, apathetic or uninterested in usual activities, severe enough to reduce a person's ability to perform everyday activities. The symptoms will gradually get worse as more brain cells become damaged and eventually die. It is noticed that more than one type of dementia may exist in the same person.

Related:  Neuropsychiatry 2018| Neuropsychiatry conferences| Neuropsychiatry conferences 2018| Psychology conferences | Neuropsychopharmacology | Psychopharmacology Meetings | Neuropsychiatry conferences Indonesia | Neuropharmacology conferences | Conference Series Ltd

5th International Conference on Brain Disorders and Therapeutics, November 29 – December  01, 2017 Madrid, Spain ; 9th International Conference on Alzheimer’s Disease & Dementia, October 16-18, 2017 Rome, Italy ; 16th International Conference on Neurology and Neuro Cognitive Disorders, October 09-10, 2017 London, UK; 7th Global Experts Meeting on Neuropharmacology July 31-Aug 02, 2017 Milan, Italy; 9th World Congress on Pharmacology, August 07-09, 2017 France;4th Clinical Trials Conference, September 11-13, 2017 San Antonio, USA; 8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 10th International Conference on Neuropharmacology and Neuropharmaceuticals, Oct 23-24, 2017 Dubai, UAE, American Board of Psychiatry and Neurology (ABPN), The American Clinical Neurophysiology Society (ACNS), ASEAN Neurological Association, Indonesian Psychological Society (HIMPSI), Indonesian pharmaceutical association (IPA), Asia Pacific Federation of Pharmacologists (ASCEPT), Indonesia Veterinary Pharmacy and Pharmacology Association (IVPPA)

 

Track18: Parkinson’s disease

Parkinson's disease is a disorder of the nervous system that affects the motor functions. It develops gradually, sometimes starting with a barely noticeable tremor in just one hand and also cause stiffness or slowing of movement. Parkinson's disease symptoms and signs may vary from person to person. Symptoms of this kind of disorder include:

  • Tremor
  • Slowed movement (bradykinesia)
  • Rigid muscles.
  • Impaired posture and balance.
  • Loss of automatic movements
  • Speech changes.
  • Writing changes.

The disorder is caused when certain nerve cells (neurons) in the brain gradually break down or die. Many of the symptoms are due to a loss of neurons that produce a chemical messenger in the brain called dopamine. When dopamine levels decrease, it causes abnormal brain activity, leading to signs of Parkinson's disease.

Related:  Neuropsychiatry 2018| Neuropsychiatry conferences| Neuropsychiatry conferences 2018| Psychology conferences | Neuropsychopharmacology | Psychopharmacology Meetings | Neuropsychiatry conferences Indonesia | Neuropharmacology conferences | Conference Series Ltd

5th International Conference on Brain Disorders and Therapeutics, November 29 – December  01, 2017 Madrid, Spain ; 9th International Conference on Alzheimer’s Disease & Dementia, October 16-18, 2017 Rome, Italy ; 16th International Conference on Neurology and Neuro Cognitive Disorders, October 09-10, 2017 London, UK; 7th Global Experts Meeting on Neuropharmacology July 31-Aug 02, 2017 Milan, Italy; 9th World Congress on Pharmacology, August 07-09, 2017 France;4th Clinical Trials Conference, September 11-13, 2017 San Antonio, USA; 8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 10th International Conference on Neuropharmacology and Neuropharmaceuticals, Oct 23-24, 2017 Dubai, UAE, American Board of Psychiatry and Neurology (ABPN), The American Clinical Neurophysiology Society (ACNS), ASEAN Neurological Association, Indonesian Psychological Society (HIMPSI), Indonesian pharmaceutical association (IPA), Asia Pacific Federation of Pharmacologists (ASCEPT), Indonesia Veterinary Pharmacy and Pharmacology Association (IVPPA)

 

Track 19: Drug addiction and alcohol dependence

Alcohol abuse means having unhealthy or dangerous drinking habits, such as drinking every day or drinking too much at a time. Symptoms includes

  • Decreased involvement in extracurricular activities.
  • Depression.
  • Lack of interest in family or friends.
  • Restlessness.
  • Inability to control drinking.
  • Erratic behavior.
  • Violent behavior

The signs and symptoms of alcohol use, as well as the short- and long-term effects of alcohol abuse don't always occur in isolation. In fact, an alarming number of people purposely combine their alcohol with drugs. Drug abuse is a serious public health problem that affects almost every community and family in some way. This is frequently done with the intention of compounding the effects of both to achieve a greater state of intoxication. Some of the drugs used include Methamphetamine, Anabolic steroids, Cocaine, Heroin, Inhalants. Drug abuse also plays a role in many major social problems, such as drugged driving, violence, stress, and child abuse. Most drugs affect the brain's "reward circuit" by flooding it with the chemical messenger dopamine.

Related:  Neuropsychiatry 2018| Neuropsychiatry conferences| Neuropsychiatry conferences 2018| Psychology conferences | Neuropsychopharmacology | Psychopharmacology Meetings | Neuropsychiatry conferences Indonesia | Neuropharmacology conferences | Conference Series Ltd

5th International Conference on Brain Disorders and Therapeutics, November 29 – December  01, 2017 Madrid, Spain ; 9th International Conference on Alzheimer’s Disease & Dementia, October 16-18, 2017 Rome, Italy ; 16th International Conference on Neurology and Neuro Cognitive Disorders, October 09-10, 2017 London, UK; 7th Global Experts Meeting on Neuropharmacology July 31-Aug 02, 2017 Milan, Italy; 9th World Congress on Pharmacology, August 07-09, 2017 France;4th Clinical Trials Conference, September 11-13, 2017 San Antonio, USA; 8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 10th International Conference on Neuropharmacology and Neuropharmaceuticals, Oct 23-24, 2017 Dubai, UAE, American Board of Psychiatry and Neurology (ABPN), The American Clinical Neurophysiology Society (ACNS), ASEAN Neurological Association, Indonesian Psychological Society (HIMPSI), Indonesian pharmaceutical association (IPA), Asia Pacific Federation of Pharmacologists (ASCEPT), Indonesia Veterinary Pharmacy and Pharmacology Association (IVPPA)

 

Track 20: Case studies and report

A case study is an account of an activity, event or problem that contains a real or hypothetical situation. Case studies can be produced by following a formal research method. These case studies are likely to appear in formal research venues, as journals and professional conferences, rather than popular works. Case studies may involve both qualitative and quantitative research methods.

A scientific report is a document that describes the process, progress, and or results of technical or scientific research or the state of a technical or scientific research problem. It might also include recommendations and conclusion of the research

Related:  Neuropsychiatry 2018| Neuropsychiatry conferences| Neuropsychiatry conferences 2018| Psychology conferences | Neuropsychopharmacology | Psychopharmacology Meetings | Neuropsychiatry conferences Indonesia | Neuropharmacology conferences | Conference Series Ltd

5th International Conference on Brain Disorders and Therapeutics, November 29 – December  01, 2017 Madrid, Spain ; 9th International Conference on Alzheimer’s Disease & Dementia, October 16-18, 2017 Rome, Italy ; 16th International Conference on Neurology and Neuro Cognitive Disorders, October 09-10, 2017 London, UK; 7th Global Experts Meeting on Neuropharmacology July 31-Aug 02, 2017 Milan, Italy; 9th World Congress on Pharmacology, August 07-09, 2017 France;4th Clinical Trials Conference, September 11-13, 2017 San Antonio, USA; 8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 10th International Conference on Neuropharmacology and Neuropharmaceuticals, Oct 23-24, 2017 Dubai, UAE, American Board of Psychiatry and Neurology (ABPN), The American Clinical Neurophysiology Society (ACNS), ASEAN Neurological Association, Indonesian Psychological Society (HIMPSI), Indonesian pharmaceutical association (IPA), Asia Pacific Federation of Pharmacologists (ASCEPT), Indonesia Veterinary Pharmacy and Pharmacology Association (IVPPA)

 

 

 

 

 

 

 

Market Analysis

Past conference report

Past Conference Report

Supported By

Journal of Neurology and Neuroscience Journal of Neuropsychopharmacology & Mental Health Journal of Psychiatry International Journal of School and Cognitive Psychology

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by